Credit Suisse’s Dyne Therapeutics DYN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.03M | Buy |
36,383
+9,525
| +35% | +$270K | ﹤0.01% | 2242 |
|
|
2023
Q4 | $357K | Sell |
26,858
-967
| -3% | -$12.9K | ﹤0.01% | 2863 |
|
|
2023
Q3 | $249K | Sell |
27,825
-5,822
| -17% | -$52.2K | ﹤0.01% | 2977 |
|
|
2023
Q2 | $379K | Buy |
33,647
+9,931
| +42% | +$112K | ﹤0.01% | 2904 |
|
|
2023
Q1 | $273K | Buy |
23,716
+5,323
| +29% | +$61.3K | ﹤0.01% | 3013 |
|
|
2022
Q4 | $213K | Buy |
18,393
+231
| +1% | +$2.68K | ﹤0.01% | 3146 |
|
|
2022
Q3 | $231K | Buy |
18,162
+147
| +0.8% | +$1.87K | ﹤0.01% | 3172 |
|
|
2022
Q2 | $124K | Buy |
18,015
+1,729
| +11% | +$11.9K | ﹤0.01% | 3467 |
|
|
2022
Q1 | $156K | Sell |
16,286
-918
| -5% | -$8.79K | ﹤0.01% | 3408 |
|
|
2021
Q4 | $204K | Buy |
17,204
+3,022
| +21% | +$35.8K | ﹤0.01% | 3434 |
|
|
2021
Q3 | $230K | Buy |
14,182
+3,176
| +29% | +$51.5K | ﹤0.01% | 3339 |
|
|
2021
Q2 | $231K | Sell |
11,006
-85,711
| -89% | -$1.8M | ﹤0.01% | 3381 |
|
|
2021
Q1 | $1.5M | Buy |
96,717
+59,520
| +160% | +$924K | ﹤0.01% | 2325 |
|
|
2020
Q4 | $781K | Buy |
37,197
+19,845
| +114% | +$417K | ﹤0.01% | 2725 |
|
|
2020
Q3 | $350K | Buy |
+17,352
| New | +$350K | ﹤0.01% | 2839 |
|